Gabi Tarcic

2.0k total citations
23 papers, 988 citations indexed

About

Gabi Tarcic is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Gabi Tarcic has authored 23 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Gabi Tarcic's work include Melanoma and MAPK Pathways (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Protein Tyrosine Phosphatases (5 papers). Gabi Tarcic is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Protein Tyrosine Phosphatases (5 papers). Gabi Tarcic collaborates with scholars based in United States, Israel and France. Gabi Tarcic's co-authors include Yosef Yarden, Ido Amit, Gordon B. Mills, Tal Shay, Jasmine Jacob‐Hirsch, Yiling Lu, Gideon Rechavi, Eytan Domany, Menachem Katz and John Lahad and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Gabi Tarcic

22 papers receiving 976 citations

Peers

Gabi Tarcic
Sekhar Duraisamy United States
Gilles Doumont Belgium
Frank P. Vendetti United States
Jason A. Sager United States
Elena Ortíz-Zapater United Kingdom
Michael P. Holloway United States
Renaud Grépin France
Yulong Liang China
Mohammad Azam United States
Tove Irene Klokk Norway
Sekhar Duraisamy United States
Gabi Tarcic
Citations per year, relative to Gabi Tarcic Gabi Tarcic (= 1×) peers Sekhar Duraisamy

Countries citing papers authored by Gabi Tarcic

Since Specialization
Citations

This map shows the geographic impact of Gabi Tarcic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabi Tarcic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabi Tarcic more than expected).

Fields of papers citing papers by Gabi Tarcic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabi Tarcic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabi Tarcic. The network helps show where Gabi Tarcic may publish in the future.

Co-authorship network of co-authors of Gabi Tarcic

This figure shows the co-authorship network connecting the top 25 collaborators of Gabi Tarcic. A scholar is included among the top collaborators of Gabi Tarcic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabi Tarcic. Gabi Tarcic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kato, Shumei, Robert Porter, Ryosuke Okamura, et al.. (2021). Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors. European Journal of Cancer. 149. 184–192. 4 indexed citations
3.
Jankú, Filip, Eric J. Sherman, Rona Yaeger, et al.. (2021). Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF. Cancer Research. 81(13_Supplement). CT212–CT212. 1 indexed citations
4.
Tarcic, Gabi, et al.. (2020). gRNA Sequence Heterology Tolerance Catalyzed by CRISPR/Cas in an In Vitro Homology-Directed Repair Reaction. Molecular Therapy — Nucleic Acids. 20. 568–579. 9 indexed citations
5.
Zimmerman, Lior, et al.. (2020). A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks. Scientific Reports. 10(1). 4192–4192. 5 indexed citations
6.
Jankú, Filip, Eric J. Sherman, Aparna R. Parikh, et al.. (2020). Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor. European Journal of Cancer. 138. S2–S3. 7 indexed citations
7.
Fairclough, Stephen R., Lesli A. Kiedrowski, W. Marston Linehan, et al.. (2019). Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort. Experimental Hematology and Oncology. 8(1). 24–24. 16 indexed citations
8.
9.
Nitzan, Erez, et al.. (2018). CRISPR-Directed In Vitro Gene Editing of Plasmid DNA Catalyzed by Cpf1 (Cas12a) Nuclease and a Mammalian Cell-Free Extract. The CRISPR Journal. 1(2). 191–202. 14 indexed citations
10.
Kamal, Maud, Gabi Tarcic, Sylvain Dureau, et al.. (2018). Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome. Molecular Oncology. 12(5). 594–601. 1 indexed citations
11.
Peled, Nir, Laila C. Roisman, Benjamin Miron, et al.. (2017). Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR -Mutated Lung Cancer. Journal of Thoracic Oncology. 12(7). e81–e84. 40 indexed citations
12.
Loree, Jonathan M., Vijaykumar Holla, Michael J. Overman, et al.. (2017). Not all RAS mutations created equal: Functional and clinical characterization of 80 different KRAS and NRAS mutations.. Journal of Clinical Oncology. 35(15_suppl). 3589–3589. 8 indexed citations
13.
Miron, Benjamin, Nir Peled, Gabi Tarcic, et al.. (2016). Functional profiling of oncogenic mutations in lung cancer patients (NCT02274025) - interim results. Annals of Oncology. 27. vi412–vi412. 1 indexed citations
14.
Tarcic, Gabi, Mohamed Kamal, Oded Edelheit, et al.. (2016). Functional mutational analysis to assess the oncogenic activity of variant of uncertain significance (VUS) detected in patients included in the SHIVA trial. European Journal of Cancer. 69. S6–S7. 2 indexed citations
15.
Tarcic, Gabi, Roi Avraham, Gur Pines, et al.. (2011). EGR1 and the ERK‐ERF axis drive mammary cell migration in response to EGF. The FASEB Journal. 26(4). 1582–1592. 78 indexed citations
16.
Tarcic, Gabi & Yosef Yarden. (2010). MAP Kinase Activation by Receptor Tyrosine Kinases: In Control of Cell Migration. Methods in molecular biology. 661. 125–135. 8 indexed citations
17.
Tarcic, Gabi, Shlomit Boguslavsky, Tai Kiuchi, et al.. (2009). An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis. Current Biology. 19(21). 1788–1798. 92 indexed citations
18.
Shema, Efrat, Itay Tirosh, Yael Aylon, et al.. (2008). The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes & Development. 22(19). 2664–2676. 224 indexed citations
19.
Amit, Ido, Ami Citri, Tal Shay, et al.. (2007). A module of negative feedback regulators defines growth factor signaling. Nature Genetics. 39(4). 503–512. 360 indexed citations
20.
Katz, Gil, Roi Gazit, Tal I. Arnon, et al.. (2004). MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4. The Journal of Immunology. 173(3). 1819–1825. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sekhar Duraisamy Breakdown of academic impact, for papers by Gilles Doumont Breakdown of academic impact, for papers by Frank P. Vendetti Breakdown of academic impact, for papers by Jason A. Sager Breakdown of academic impact, for papers by Elena Ortíz-Zapater Breakdown of academic impact, for papers by Michael P. Holloway Breakdown of academic impact, for papers by Renaud Grépin Breakdown of academic impact, for papers by Yulong Liang Breakdown of academic impact, for papers by Mohammad Azam Breakdown of academic impact, for papers by Tove Irene Klokk
Rankless by CCL
2026